ArticleHeart (British Cardiac Society)2002
Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.
T Reffelmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.